Race and gender variation in response to evoked inflammation

Journal of Translational Medicine

Volumn 11, Issue 1, 2013, Pages

  Ferguson, Jane F ^a   Patel, Parth N ^a   Shah, Rhia Y ^a   Mulvey, Claire K ^a   Gadi, Ram ^a   Nijjar, Prabhjot S ^b   Usman, Haris M ^a   Mehta, Nehal N ^a,c   Shah, Rachana ^d   Master, Stephen R ^a   Propert, Kathleen J ^a   Reilly, Muredach P ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PROTEIN; C REACTIVE PROTEIN; INTERLEUKIN 6;

ADULT; AFRICAN; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DISEASE ASSOCIATION; ENDOTOXEMIA; ETHNIC GROUP; ETHNICITY; EVOKED RESPONSE; FEMALE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MALE; OUTCOME ASSESSMENT; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN FUNCTION; RACE DIFFERENCE; SEX DIFFERENCE;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; ENDOTOXEMIA; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY, INNATE; INFLAMMATION; MALE; NIACIN; SEX FACTORS; YOUNG ADULT;

EID: 84874778798     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-11-63     Document Type: Article

References (43)

1. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006, 444:860-867. 10.1038/nature05485, 17167474.
2. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352:1685-1695. 10.1056/NEJMra043430, 15843671.
3. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011, 123:e18-e209. 10.1161/CIR.0b013e3182009701, 21160056.
4. Mayr FB, Yende S, Linde-Zwirble WT, Peck-Palmer OM, Barnato AE, Weissfeld LA, Angus DC. Infection rate and acute organ dysfunction risk as explanations for racial differences in severe sepsis. JAMA 2010, 303:2495-2503. 10.1001/jama.2010.851, 20571016.
5. Adrie C, Azoulay E, Francais A, Clec'h C, Darques L, Schwebel C, Nakache D, Jamali S, Goldgran-Toledano D, Garrouste-Orgeas M, Timsit JF. Influence of gender on the outcome of severe sepsis: a reappraisal. Chest 2007, 132:1786-1793. 10.1378/chest.07-0420, 17890473.
6. Cohen J, Pertsemlidis A, Kotowski IK, Graham R, Garcia CK, Hobbs HH. Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9. Nat Genet 2005, 37:161-165. 10.1038/ng1509, 15654334.
7. Paalani M, Lee JW, Haddad E, Tonstad S. Determinants of inflammatory markers in a bi-ethnic population. Ethn Dis 2011, 21:142-149. 3427005, 21749016.
8. Rhew EY, Manzi SM, Dyer AR, Kao AH, Danchenko N, Barinas-Mitchell E, Sutton-Tyrrell K, McPherson DD, Pearce W, Edmundowicz D. Differences in subclinical cardiovascular disease between African American and Caucasian women with systemic lupus erythematosus. Transl Res 2009, 153:51-59. 10.1016/j.trsl.2008.11.006, 2674850, 19138649.
9. Cao JJ, Arnold AM, Manolio TA, Polak JF, Psaty BM, Hirsch CH, Kuller LH, Cushman M. Association of carotid artery intima-media thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality: the Cardiovascular Health Study. Circulation 2007, 116:32-38. 10.1161/CIRCULATIONAHA.106.645606, 17576871.
10. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Gallimore JR, Pepys MB. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 2000, 321:199-204. 10.1136/bmj.321.7255.199, 27435, 10903648.
11. Hudgins LC, Parker TS, Levine DM, Gordon BR, Saal SD, Jiang XC, Seidman CE, Tremaroli JD, Lai J, Rubin AL. A single intravenous dose of endotoxin rapidly alters serum lipoproteins and lipid transfer proteins in normal volunteers. J Lipid Res 2003, 44:1489-1498. 10.1194/jlr.M200440-JLR200, 12754273.
12. Anderson PD, Mehta NN, Wolfe ML, Hinkle CC, Pruscino L, Comiskey LL, Tabita-Martinez J, Sellers KF, Rickels MR, Ahima RS, Reilly MP. Innate immunity modulates adipokines in humans. J Clin Endocrinol Metab 2007, 92:2272-2279. 10.1210/jc.2006-2545, 17374708.
13. Mehta NN, McGillicuddy FC, Anderson PD, Hinkle CC, Shah R, Pruscino L, Tabita-Martinez J, Sellers KF, Rickels MR, Reilly MP. Experimental Endotoxemia Induces Adipose Inflammation and Insulin Resistance in Humans. Diabetes 2010, 59:172-181. 10.2337/db09-0367, 2797919, 19794059.
14. Agwunobi AO, Reid C, Maycock P, Little RA, Carlson GL. Insulin resistance and substrate utilization in human endotoxemia. J Clin Endocrinol Metab 2000, 85:3770-3778. 10.1210/jc.85.10.3770, 11061537.
15. Suffredini AF, Fromm RE, Parker MM, Brenner M, Kovacs JA, Wesley RA, Parrillo JE. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 1989, 321:280-287. 10.1056/NEJM198908033210503, 2664516.
16. Mehta NN, Heffron SP, Patel PN, Ferguson J, Shah RD, Hinkle CC, Krishnamoorthy P, Shah R, Tabita-Martinez J, Terembula K. A human model of inflammatory cardio-metabolic dysfunction; a double blind placebo-controlled crossover trial. J Transl Med 2012, 10:124. 10.1186/1479-5876-10-124, 3477112, 22709547.
17. Pasterkamp G, Van Keulen JK, De Kleijn DP. Role of Toll-like receptor 4 in the initiation and progression of atherosclerotic disease. Eur J Clin Invest 2004, 34:328-334. 10.1111/j.1365-2362.2004.01338.x, 15147329.
18. Tsukumo DM, Carvalho-Filho MA, Carvalheira JB, Prada PO, Hirabara SM, Schenka AA, Araujo EP, Vassallo J, Curi R, Velloso LA, Saad MJ. Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 2007, 56:1986-1998. 10.2337/db06-1595, 17519423.
19. Michelsen KS, Wong MH, Shah PK, Zhang W, Yano J, Doherty TM, Akira S, Rajavashisth TB, Arditi M. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci USA 2004, 101:10679-10684. 10.1073/pnas.0403249101, 489994, 15249654.
20. Heffron SP, Parastatidis I, Cuchel M, Wolfe ML, Tadesse MG, Mohler ER, Ischiropoulos H, Rader DJ, Reilly MP. Inflammation induces fibrinogen nitration in experimental human endotoxemia. Free Radic Biol Med 2009, 47:1140-1146. 10.1016/j.freeradbiomed.2009.07.025, 19631267.
21. McGillicuddy FC, de la Llera MM, Hinkle CC, Joshi MR, Chiquoine EH, Billheimer JT, Rothblat GH, Reilly MP. Inflammation impairs reverse cholesterol transport in vivo. Circulation 2009, 119:1135-1145. 10.1161/CIRCULATIONAHA.108.810721, 19221221.
22. Kiechl S, Lorenz E, Reindl M, Wiedermann CJ, Oberhollenzer F, Bonora E, Willeit J, Schwartz DA. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 2002, 347:185-192. 10.1056/NEJMoa012673, 12124407.
23. Cagnacci A, Soldani R, Laughlin GA, Yen SS. Modification of circadian body temperature rhythm during the luteal menstrual phase: role of melatonin. J Appl Physiol 1996, 80:25-29. 10.1063/1.362782, 8847311.
24. Worns MA, Victor A, Galle PR, Hohler T. Genetic and environmental contributions to plasma C-reactive protein and interleukin-6 levels-a study in twins. Genes Immun 2006, 7:600-605. 10.1038/sj.gene.6364330, 16900203.
25. Saxena S, Wong ET. Heterogeneity of common hematologic parameters among racial, ethnic, and gender subgroups. Arch Pathol Lab Med 1990, 114:715-719.
26. Ulevitch RJ, Johnston AR, Weinstein DB. New function for high density lipoproteins. Their participation in intravascular reactions of bacterial lipopolysaccharides. J Clin Invest 1979, 64:1516-1524. 10.1172/JCI109610, 371301, 227936.
27. Vreugdenhil AC, Snoek AM, Van't Veer C, Greve JW, Buurman WA. LPS-binding protein circulates in association with apoB-containing lipoproteins and enhances endotoxin-LDL/VLDL interaction. J Clin Invest 2001, 107:225-234. 10.1172/JCI10832, 199173, 11160139.
28. Mayr FB, Spiel AO, Leitner JM, Firbas C, Kliegel T, Jilma-Stohlawetz P, Derendorf H, Jilma B. Duffy antigen modifies the chemokine response in human endotoxemia. Crit Care Med 2008, 36:159-165. 10.1097/01.CCM.0000297875.55969.DB, 18007272.
29. Pradhan AD, Manson JE, Rossouw JE, Siscovick DS, Mouton CP, Rifai N, Wallace RB, Jackson RD, Pettinger MB, Ridker PM. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. JAMA 2002, 288:980-987. 10.1001/jama.288.8.980, 12190368.
30. Khera A, McGuire DK, Murphy SA, Stanek HG, Das SR, Vongpatanasin W, Wians FH, Grundy SM, de Lemos JA. Race and gender differences in C-reactive protein levels. J Am Coll Cardiol 2005, 46:464-469. 10.1016/j.jacc.2005.04.051, 16053959.
31. Steffen BT, Steffen LM, Tracy R, Siscovick D, Jacobs D, Liu K, He K, Hanson NQ, Nettleton JA, Tsai MY. Ethnicity, plasma phospholipid fatty acid composition and inflammatory/endothelial activation biomarkers in the Multi-Ethnic Study of Atherosclerosis (MESA). Eur J Clin Nutr 2012, 66:600-605. 10.1038/ejcn.2011.215, 22215136.
32. Morris M, Li L. Molecular mechanisms and pathological consequences of endotoxin tolerance and priming. Arch Immunol Ther Exp (Warsz) 2012, 60:13-18.
33. Pozzoli U, Fumagalli M, Cagliani R, Comi GP, Bresolin N, Clerici M, Sironi M. The role of protozoa-driven selection in shaping human genetic variability. Trends Genet 2010, 26:95-99. 10.1016/j.tig.2009.12.010, 20097439.
34. Plantinga TS, Ioana M, Alonso S, Izagirre N, Hervella M, Joosten LA, van der Meer JW, de la Rua C, Netea MG. The evolutionary history of TLR4 polymorphisms in Europe. J Innate Immun 2012, 4:168-175. 10.1159/000329492, 21968286.
35. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56:1761-1772. 10.2337/db06-1491, 17456850.
36. van Eijk LT, Dorresteijn MJ, Smits P, van der Hoeven JG, Netea MG, Pickkers P. Gender differences in the innate immune response and vascular reactivity following the administration of endotoxin to human volunteers. Crit Care Med 2007, 35:1464-1469. 10.1097/01.CCM.0000266534.14262.E8, 17452928.
37. Coyle SM, Calvano SE, Lowry SF. Gender influences in vivo human responses to endotoxin. Shock 2006, 26:538-543. 10.1097/01.shk.0000232589.39001.4d, 17117126.
38. Copeland S, Warren HS, Lowry SF, Calvano SE, Remick D. Acute inflammatory response to endotoxin in mice and humans. Clin Diagn Lab Immunol 2005, 12:60-67. 540200, 15642986.
39. Armah KA, McGinnis K, Baker J, Gibert C, Butt AA, Bryant KJ, Goetz M, Tracy R, Oursler KK, Rimland D. HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation. Clin Infect Dis 2012, 55:126-136. 10.1093/cid/cis406, 22534147.
40. Shah R, Lu Y, Hinkle CC, McGillicuddy FC, Kim R, Hannenhalli S, Cappola TP, Heffron S, Wang X, Mehta NN. Gene profiling of human adipose tissue during evoked inflammation in vivo. Diabetes 2009, 58:2211-2219. 10.2337/db09-0256, 2750231, 19581417.
41. Moreira AP, Texeira TF, Ferreira AB, Peluzio Mdo C, Alfenas Rde C. Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia. Br J Nutr 2012, 108:801-809. 10.1017/S0007114512001213, 22717075.
42. Koren O, Spor A, Felin J, Fak F, Stombaugh J, Tremaroli V, Behre CJ, Knight R, Fagerberg B, Ley RE, Backhed F. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci USA 2011, 108(Suppl 1):4592-4598. 3063583, 20937873.
43. Amar J, Serino M, Lange C, Chabo C, Iacovoni J, Mondot S, Lepage P, Klopp C, Mariette J, Bouchez O. Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept. Diabetologia 54:3055-3061.